Cargando…

Twenty Years of Targeted Treatment in Rheumatoid Arthritis in the Greek Databases: Achievements and Unmet Needs

Rheumatoid arthritis (RA) is a chronic autoimmune disease associated with substantial morbidity and mortality especially in difficult to treat cases. Biologic agents were introduced 20 years ago in Greece and RA management has paralleled the European experience. Several publications from the country...

Descripción completa

Detalles Bibliográficos
Autores principales: Sidiropoulos, Prodromos, Sfikakis, Petros P., Boumpas, Dimitrios D., Vassilopoulos, Dimitrios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Mediterranean Journal of Rheumatology (MJR) 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045862/
https://www.ncbi.nlm.nih.gov/pubmed/32185356
http://dx.doi.org/10.31138/mjr.30.3.141
_version_ 1783501860508794880
author Sidiropoulos, Prodromos
Sfikakis, Petros P.
Boumpas, Dimitrios D.
Vassilopoulos, Dimitrios
author_facet Sidiropoulos, Prodromos
Sfikakis, Petros P.
Boumpas, Dimitrios D.
Vassilopoulos, Dimitrios
author_sort Sidiropoulos, Prodromos
collection PubMed
description Rheumatoid arthritis (RA) is a chronic autoimmune disease associated with substantial morbidity and mortality especially in difficult to treat cases. Biologic agents were introduced 20 years ago in Greece and RA management has paralleled the European experience. Several publications from the country have captured important aspects of the disease from its epidemiology to the clinical use of biologics and management of comorbidities. In this communication we review the management of RA and its evolution over the last 20 years in Greece, discussing the major achievements and the unmet needs of the disease in an effort to put this into a perspective. We conclude that introduction of biologic therapy has substantially changed the treatment of difficult to treat rheumatoid arthritis in-spite of the multiple unmet needs. While striving for even better outcomes, we cannot lose sight of the major impact of biologic therapies on the lives of patients with rheumatoid arthritis.
format Online
Article
Text
id pubmed-7045862
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher The Mediterranean Journal of Rheumatology (MJR)
record_format MEDLINE/PubMed
spelling pubmed-70458622020-03-17 Twenty Years of Targeted Treatment in Rheumatoid Arthritis in the Greek Databases: Achievements and Unmet Needs Sidiropoulos, Prodromos Sfikakis, Petros P. Boumpas, Dimitrios D. Vassilopoulos, Dimitrios Mediterr J Rheumatol Commentary Rheumatoid arthritis (RA) is a chronic autoimmune disease associated with substantial morbidity and mortality especially in difficult to treat cases. Biologic agents were introduced 20 years ago in Greece and RA management has paralleled the European experience. Several publications from the country have captured important aspects of the disease from its epidemiology to the clinical use of biologics and management of comorbidities. In this communication we review the management of RA and its evolution over the last 20 years in Greece, discussing the major achievements and the unmet needs of the disease in an effort to put this into a perspective. We conclude that introduction of biologic therapy has substantially changed the treatment of difficult to treat rheumatoid arthritis in-spite of the multiple unmet needs. While striving for even better outcomes, we cannot lose sight of the major impact of biologic therapies on the lives of patients with rheumatoid arthritis. The Mediterranean Journal of Rheumatology (MJR) 2019-09-30 /pmc/articles/PMC7045862/ /pubmed/32185356 http://dx.doi.org/10.31138/mjr.30.3.141 Text en © 2019 The Mediterranean Journal of Rheumatology (MJR) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
spellingShingle Commentary
Sidiropoulos, Prodromos
Sfikakis, Petros P.
Boumpas, Dimitrios D.
Vassilopoulos, Dimitrios
Twenty Years of Targeted Treatment in Rheumatoid Arthritis in the Greek Databases: Achievements and Unmet Needs
title Twenty Years of Targeted Treatment in Rheumatoid Arthritis in the Greek Databases: Achievements and Unmet Needs
title_full Twenty Years of Targeted Treatment in Rheumatoid Arthritis in the Greek Databases: Achievements and Unmet Needs
title_fullStr Twenty Years of Targeted Treatment in Rheumatoid Arthritis in the Greek Databases: Achievements and Unmet Needs
title_full_unstemmed Twenty Years of Targeted Treatment in Rheumatoid Arthritis in the Greek Databases: Achievements and Unmet Needs
title_short Twenty Years of Targeted Treatment in Rheumatoid Arthritis in the Greek Databases: Achievements and Unmet Needs
title_sort twenty years of targeted treatment in rheumatoid arthritis in the greek databases: achievements and unmet needs
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045862/
https://www.ncbi.nlm.nih.gov/pubmed/32185356
http://dx.doi.org/10.31138/mjr.30.3.141
work_keys_str_mv AT sidiropoulosprodromos twentyyearsoftargetedtreatmentinrheumatoidarthritisinthegreekdatabasesachievementsandunmetneeds
AT sfikakispetrosp twentyyearsoftargetedtreatmentinrheumatoidarthritisinthegreekdatabasesachievementsandunmetneeds
AT boumpasdimitriosd twentyyearsoftargetedtreatmentinrheumatoidarthritisinthegreekdatabasesachievementsandunmetneeds
AT vassilopoulosdimitrios twentyyearsoftargetedtreatmentinrheumatoidarthritisinthegreekdatabasesachievementsandunmetneeds